Drug name - Dilaudid

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9731082 FRESENIUS KABI USA Drug container Apr, 2032

(9 years from now)

US9248229 FRESENIUS KABI USA Packaging system for oxygen-sensitive drugs Mar, 2034

(11 years from now)

More Information on Dosage
Strength Dosage Availability
0.2MG/ML INJECTABLE;INJECTION Prescription
1MG/ML INJECTABLE;INJECTION Prescription
2MG/ML INJECTABLE;INJECTION Prescription
4MG/ML INJECTABLE;INJECTION Discontinued
10MG/ML INJECTABLE;INJECTION Discontinued
250MG/VIAL INJECTABLE;INJECTION Discontinued

availability in other generic markets.

Click on the highlighted region to filter.